Shares of Thermo Fisher Scientific dropped in intraday trading Wednesday after the medical device maker gave lower-than-expected guidance for 2024 as biotech companies rein in product spending.
Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback